AXL-directed antibody-drug conjugate therapy in soft-tissue sarcoma.

El-Ghazzi N, Sourisseau T, Chaire V, Del Ben T, Derieppe MA, Vanhersecke L, Rey C, Bessede A, Pasquet JM, Italiano A

Open source

DOI
10.1186/s13045-026-01851-1
Published
2026 Oct 16
Container
Journal of hematology & oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13045-026-01851-1,
  title = {AXL-directed antibody-drug conjugate therapy in soft-tissue sarcoma.},
  author = {El-Ghazzi N and Sourisseau T and Chaire V and Del Ben T and Derieppe MA and Vanhersecke L and Rey C and Bessede A and Pasquet JM and Italiano A},
  year = {2026},
  journal = {Journal of hematology \& oncology},
  doi = {10.1186/s13045-026-01851-1},
  url = {https://doi.org/10.1186/s13045-026-01851-1}
}

RIS

TY  - JOUR
TI  - AXL-directed antibody-drug conjugate therapy in soft-tissue sarcoma.
AU  - El-Ghazzi N
AU  - Sourisseau T
AU  - Chaire V
AU  - Del Ben T
AU  - Derieppe MA
AU  - Vanhersecke L
AU  - Rey C
AU  - Bessede A
AU  - Pasquet JM
AU  - Italiano A
PY  - 2026
JO  - Journal of hematology & oncology
DO  - 10.1186/s13045-026-01851-1
UR  - https://doi.org/10.1186/s13045-026-01851-1
ER  - 

APA

N, E., T, S., V, C., T, D. B., MA, D., L, V., C, R., A, B., JM, P., & A, I. (2026). AXL-directed antibody-drug conjugate therapy in soft-tissue sarcoma.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-026-01851-1

Source records